Also, EGF/EGFR system impairment occurred by the cetuximab was found to be related to the ability to initiate a growth arrest in phases of G2/M in CRC cells that subsequently lead to a decrease in P21 (Li X et al..2010). Here, EGFR is linked to colorectal carcinoma.